World's Best Scientists 2026 revealed!
Kristian Wachtell

Kristian Wachtell

D-Index & Metrics

Medicine

D-Index
75
Citations
25661
World Ranking
19030
National Ranking
9489

Kristian Wachtell publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Kristian Wachtell sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 421 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Kristian Wachtell D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Kristian Wachtell sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 75 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Kristian Wachtell is affiliated with Cornell University in the United States and has contributed extensively to medical research, focusing primarily on cardiology and cardiovascular medicine. Their work encompasses diverse subfields, including surgery, endocrinology, diabetes and metabolism, radiology, nuclear medicine and imaging, and biomedical engineering.

Their research is notably centered around several main topics, which include:

  • Blood Pressure and Hypertension Studies
  • Cardiac Valve Diseases and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics
  • Heart Rate Variability and Autonomic Control
  • Mechanical Circulatory Support Devices

Kristian Wachtell has published frequently in several key medical journals, with notable recurring publication venues such as:

  • European Heart Journal
  • Journal of Hypertension
  • Hypertension
  • Exploration of Medicine
  • The Lancet

Co-authorship has been an important aspect of Wachtell's research output. Frequent collaborators include:

  • Sverre E. Kjeldsen
  • Stevo Julius
  • Peter M. Okin
  • Anders M. Greve
  • Richard B. Devereux

Among recent papers, Wachtell's contributions cover a range of cardiovascular topics, including:

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure, 2021, The Lancet
  • Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock, 2024, New England Journal of Medicine
  • Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk, 2020, Circulation
  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis, 2021, The Lancet
  • Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis, 2021, The Lancet Oncology

Wachtell's publications reflect a consistent emphasis on investigating blood pressure management, cardiovascular risk factors, and interventions for heart disease, contributing to both clinical and epidemiological understandings within the field of cardiovascular medicine.

Best Publications

  • Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

    Anne B. Rossebø;Terje R. Pedersen;Kurt Boman;Philippe Brudi

  • Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study

    Kristian Wachtell;Mika Lehto;Eva Gerdts;Michael H. Olsen

  • Prognostic significance of left ventricular mass change during treatment of hypertension

    Richard B Devereux;Kristian Wachtell;Eva Gerdts;Krister K. Boman

  • A Call to Action and a Lifecourse Strategy to Address the Global Burden of Raised Blood Pressure on Current and Future Generations: The Lancet Commission on Hypertension

    Michael H. Olsen;Michael H. Olsen;Sonia Y. Angell;Samira Asma;Pierre Boutouyrie

  • Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study

    Kristian Wachtell;Hans Ibsen;Michael H. Olsen;Knut Borch-Johnsen

  • Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients. Losartan Intervention for Endpoint Reduction in Hypertension Study

    Hans Ibsen;Michael H. Olsen;Kristian Wachtell;Knut Borch-Johnsen

  • Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial

    Richard B. Devereux;Björn Dahlöf;Eva Gerdts;Kurt Boman

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

    Kazem Rahimi;Zeinab Bidel;Milad Nazarzadeh;Emma Copland

  • Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.

    Lars H. Lindholm;Hans Ibsen;Knut Borch-Johnsen;Michael Hecht Olsen

  • Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition: A Meta-Analysis

    Markus P. Schneider;Tsushung A. Hua;Michael Böhm;Kristian Wachtell

  • Risk prediction is improved by adding markers of subclinical organ damage to SCORE.

    Thomas Sehestedt;Jørgen Jeppesen;Tine W. Hansen;Kristian Wachtell

  • Short- and long-term cause of death in patients treated with primary PCI for STEMI.

    Frants Pedersen;Vitalij Butrymovich;Henning Kelbæk;Kristian Wachtell

  • Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction

    Nikolaus Jander;Jan Minners;Ingar Holme;Eva Gerdts

  • Regression of Electrocardiographic Left Ventricular Hypertrophy and Decreased Incidence of New-Onset Atrial Fibrillation in Patients With Hypertension

    Peter M. Okin;Kristian Wachtell;Richard B. Devereux;Katherine E. Harris

  • Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

    Kristian Wachtell;Björn Hornestam;Mika Lehto;David J. Slotwiner

  • Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy and Reduction in Sudden Cardiac Death The LIFE Study

    Kristian Wachtell;Peter M Okin;Michael H Olsen;Björn Dahlöf

  • Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients

    Peter Willeit;Lena Tschiderer;Elias Allara;Kathrin Reuber

  • Correlates of Left Atrial Size in Hypertensive Patients With Left Ventricular Hypertrophy: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study

    Eva Gerdts;Lasse Oikarinen;Vittorio Palmieri;Jan Erik Otterstad

  • Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment. Losartan Intervention for Endpoint Reduction in Hypertension Trial

    Eva Gerdts;Kristian Wachtell;Per Omvik;Jan Erik Otterstad

  • Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: The LIFE Study

    Hans Ibsen;Kristian Wachtell;Michael H. Olsen;Knut Borch-JohnseN

Frequent Co-Authors

Richard B. Devereux
Richard B. Devereux Cornell University
Björn Dahlöf
Björn Dahlöf Sahlgrenska University Hospital
Markku S. Nieminen
Markku S. Nieminen University of Helsinki
Sverre E. Kjeldsen
Sverre E. Kjeldsen University of Oslo
Peter M. Okin
Peter M. Okin Cornell University
Stevo Julius
Stevo Julius University of Michigan–Ann Arbor
Lars Køber
Lars Køber Copenhagen University Hospital
Giovanni de Simone
Giovanni de Simone University of Naples Federico II
Terje R. Pedersen
Terje R. Pedersen Oslo University Hospital
Christoph A. Nienaber
Christoph A. Nienaber National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine, there are several online programs that can broaden your career options in healthcare. A healthcare administration degree online prepares you for vital roles in hospital management, health policy, and operational leadership. This flexible option is ideal if you wish to work on the business side of healthcare.

If you already hold a bachelor’s degree, consider the cheapest online master degree in healthcare administration to further advance your administrative skills and expand your job prospects in the ever-growing healthcare sector.

Nursing professionals looking to move into advanced practice or leadership can explore msn to dnp programs online. These Doctor of Nursing Practice programs help you develop expertise in clinical care, policy, and healthcare systems.

For those interested in pharmacy, an online pharmacy degree provides flexible training to become a licensed pharmacist, blending science, research, and patient care in a rewarding career pathway.

Best Scientists Citing Kristian Wachtell

Trending Scientists

Recently Published Articles